Joseph Edelman, Director

Joseph Edelman founded Perceptive Advisors, LLC in 1999, a hedge fund focused on supporting the progress of the life sciences industry. Under Joe’s leadership, Perceptive has grown into one of the largest and most successful life sciences funds with over $2 billion of assets under management by applying thorough due diligence and insights in assessing technologies for investment. The firm oversees a portfolio of investments in various therapeutic areas across all stages of development and commercialization. Perceptive has increasingly led seed and early financing rounds in private life sciences companies from company formation through the development life cycle. Previously, Joe was Senior Analyst at Aries Fund, a Paramount Capital Asset Management biotechnology hedge fund, from 1994 through 1998. Prior to Aries Fund, he was Senior Biotechnology Analyst at Prudential Securities for four years, after starting his career in the healthcare sector of the securities industry as Biotechnology Analyst at Labe, Simpson. Joe earned an MBA from New York University and a BA, magna cum laude, in psychology from the University of California, San Diego.